Show simple item record

A dominant role for the methyl-CpG-binding protein Mbd2 in controlling Th2 induction by dendritic cells.

dc.contributor.authorCook, Peter
dc.contributor.authorOwen, Heather
dc.contributor.authorDeaton, Aimée M
dc.contributor.authorBorger, Jessica G
dc.contributor.authorBrown, Sheila
dc.contributor.authorClouaire, Thomas
dc.contributor.authorJones, Gareth-Rhys
dc.contributor.authorJones, Lucy H
dc.contributor.authorLundie, Rachel J
dc.contributor.authorMarley, Angela K
dc.contributor.authorMorrison, Vicky L
dc.contributor.authorPhythian-Adams, Alexander
dc.contributor.authorWachter, Elisabeth
dc.contributor.authorWebb, Lauren
dc.contributor.authorSutherland, Tara
dc.contributor.authorThomas, Graham D
dc.contributor.authorGrainger, John R
dc.contributor.authorSelfridge, Jim
dc.contributor.authorMcKenzie, Andrew N J
dc.contributor.authorAllen, Judith
dc.contributor.authorFagerholm, Susanna C
dc.contributor.authorMaizels, Rick M
dc.contributor.authorIvens, Alasdair C
dc.contributor.authorBird, Adrian
dc.contributor.authorMacDonald, Andrew S
dc.date.accessioned2022-12-01T00:03:41Z
dc.date.available2022-12-01T00:03:41Z
dc.date.issued2015-04-24
dc.identifier219648766
dc.identifier2f7e7055-4e97-4572-992a-88f679c9d520
dc.identifier84928805959
dc.identifier.citationCook , P , Owen , H , Deaton , A M , Borger , J G , Brown , S , Clouaire , T , Jones , G-R , Jones , L H , Lundie , R J , Marley , A K , Morrison , V L , Phythian-Adams , A , Wachter , E , Webb , L , Sutherland , T , Thomas , G D , Grainger , J R , Selfridge , J , McKenzie , A N J , Allen , J , Fagerholm , S C , Maizels , R M , Ivens , A C , Bird , A & MacDonald , A S 2015 , ' A dominant role for the methyl-CpG-binding protein Mbd2 in controlling Th2 induction by dendritic cells. ' , Nature Communications , vol. 6 , 6920 . https://doi.org/10.1038/ncomms7920en
dc.identifier.issn2041-1723
dc.identifier.otherBibtex: 40e4d0d916324cafb4296b6ee9488d9c
dc.identifier.otherORCID: /0000-0001-9334-8206/work/120622553
dc.identifier.urihttp://aura-test.abdn.ac.uk/handle/2164/19314
dc.descriptionAcknowledgements This work was supported by the M.R.C. (G0701437 to A.S.M.) and the Wellcome Trust, Cancer Research United Kingdom and the B.B.S.R.C (A.B., L.H.J., G-R.J., G.D.T., J.R.G., R.M.M., S.C.F. and V.L.M.). DNA sequencing was managed and performed at the Wellcome Trust Sanger Institute. Illumina BeadChip experiments were performed at the Wellcome Trust Clinical Research Facility, Edinburgh, by Louise Evenden and Lee Murphy. We thank Rinku Rajan for technical support; Yoshihide Kanaoka for advice on the HDM protocol; Martin Waterfall for cell sorting and assistance with flow cytometry; Mark Travis and John Worthington for supplying transforming growth factor-β; and David Gray, Caetano Reis e Sousa, Kevin Couper and Markus Mohrs for provision of IL-10eGFP, CD11cCre and KN2 mice. Schistosome life cycle stages used to generate eggs and SEA for this research were supplied by the N.I.A.I.D. Schistosomiasis Resource Center at the Biomedical Research Institute (Rockville, MD, USA) through Contract N01-AI-30026.en
dc.format.extent1644002
dc.language.isoeng
dc.relation.ispartofNature Communicationsen
dc.subjectSDG 3 - Good Health and Well-beingen
dc.subjectR Medicineen
dc.subjectMedical Research Council (MRC)en
dc.subjectG0701437en
dc.subjectBiotechnology and Biological Sciences Research Council (BBSRC)en
dc.subjectCancer Research UKen
dc.subjectWellcome Trusten
dc.subjectSupplementary Dataen
dc.subject.lccRen
dc.titleA dominant role for the methyl-CpG-binding protein Mbd2 in controlling Th2 induction by dendritic cells.en
dc.typeJournal articleen
dc.contributor.institutionUniversity of Aberdeen.Medical Sciencesen
dc.description.statusPeer revieweden
dc.identifier.doihttps://doi.org/10.1038/ncomms7920
dc.identifier.vol6en


Files in this item

Thumbnail
Name:
Adams_etal_RD_We_re_all_in_AAM.pdf
Size:
1.060Mb
Format:
PDF
View/Open

This item appears in the following Collection(s)

Show simple item record